NCT02283827View on ClinicalTrials.gov

Open-label Drug Interaction Study Between Eslicarbazepine Acetate and Phenytoin.

PHASE1CompletedINTERVENTIONAL

Enrollment

32

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

March 31, 2007

Study Completion Date

March 31, 2007

Conditions

Epilepsy

Interventions

DRUG

BIA 2-093

DRUG

Phenytoin

All Listed Sponsors

lead

Bial - Portela C S.A.

INDUSTRY

NCT02283827 - Open-label Drug Interaction Study Between Eslicarbazepine Acetate and Phenytoin. | Biotech Hunter | Biotech Hunter